Cargando…

Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia

Eosinophils are important mediators of mucosal tissue homeostasis, anti-helminth responses, and allergy. Lung eosinophilia has previously been linked to aberrant Type 2-skewed T cell responses to respiratory viral infection and may also be a consequence of vaccine-associated enhanced respiratory dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Lauren A., Choi, Angela, Rathnasinghe, Raveen, Warang, Prajakta, Noureddine, Moataz, Jangra, Sonia, Chen, Yong, De Geest, Bruno G., Schotsaert, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437116/ https://www.ncbi.nlm.nih.gov/pubmed/37600776 http://dx.doi.org/10.3389/fimmu.2023.1217181

Ejemplares similares

RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine
por: Jangra, Sonia, et al.
Publicado: (2022)

The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice
por: Jangra, Sonia, et al.
Publicado: (2023)

Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine
por: Jangra, Sonia, et al.
Publicado: (2021)

Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters
por: García-Bernalt Diego, Juan, et al.
Publicado: (2023)

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
por: Jangra, Sonia, et al.
Publicado: (2021)

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
por: Jangra, Sonia, et al.
Publicado: (2021)

A multicomponent intranasal adjuvant drives durable humoral, cellular, and mucosal immune responses to SARS-CoV-2 in young and aged mice
por: Jangra, Sonia, et al.
Publicado: (2023)

Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes
por: Nogales, Aitor, et al.
Publicado: (2021)

Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine
por: Jangra, Sonia, et al.
Publicado: (2020)

The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model
por: Amanat, Fatima, et al.
Publicado: (2020)

Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
por: Amanat, Fatima, et al.
Publicado: (2021)

RSV Infection in Neonatal Mice Induces Pulmonary Eosinophilia Responsible for Asthmatic Reaction
por: Zhang, Dan, et al.
Publicado: (2022)

Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultraviolet C (UVC) irradiation device
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses
por: Choi, Angela, et al.
Publicado: (2020)

Editorial: Pandemic influenza vaccine approaches: Current status and future directions
por: Schotsaert, Michael, et al.
Publicado: (2022)

Allergen Exposure in Lymphopenic Fas-Deficient Mice Results in Persistent Eosinophilia Due to Defects in Resolution of Inflammation
por: Ferreira, Caroline M., et al.
Publicado: (2018)

Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera
por: Rathnasinghe, Raveen, et al.
Publicado: (2022)

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Rescue of alveolar wall liquid secretion blocks fatal lung injury due to influenza-staphylococcal coinfection
por: Tang, Stephanie, et al.
Publicado: (2023)

Myeloid Protease-Activated Receptor-2 Contributes to Influenza A Virus Pathology in Mice
por: Gunther, Randall C., et al.
Publicado: (2021)

Breakthrough of glycobiology in the 21st century
por: Mahara, Gehendra, et al.
Publicado: (2023)

The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid
por: Messingham, Kelly N., et al.
Publicado: (2019)

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Neoantigen: A New Breakthrough in Tumor Immunotherapy
por: Zhang, Zheying, et al.
Publicado: (2021)

Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality
por: Rai, Shinya, et al.
Publicado: (2019)

Inhibition of Bcl2L12 Attenuates Eosinophilia-Related Inflammation in the Heart
por: Chen, Xiao, et al.
Publicado: (2020)

Case Report: Non-episodic Angioedema With Eosinophilia in a Young Lactating Woman
por: Hirmatsu-Ito, Mizuho, et al.
Publicado: (2021)

Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections
por: Ahmed, Mohamed Ibraheem Mahmoud, et al.
Publicado: (2022)

Host immune response–inspired development of the influenza vaccine
por: Choi, Angela, et al.
Publicado: (2020)

Retraction: Inhibition of Bcl2L12 attenuates eosinophilia-related inflammation in heart
Publicado: (2023)

Latent Strongyloides stercoralis in an Asymptomatic Male With Chronic Peripheral Eosinophilia
por: Rasul, Taha F, et al.
Publicado: (2021)

Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy
por: Wright, Benjamin L., et al.
Publicado: (2018)

Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome
por: Rubin, Limor, et al.
Publicado: (2023)

Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results
por: Mastelic-Gavillet, Beatris, et al.
Publicado: (2019)

The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract
por: Bonaz, Bruno, et al.
Publicado: (2017)

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q8k76p47o03gvf6170u87dqv0i